Why the study?
Does the Perimount Magna bioprosthesis improve hemodynamic performance and reduce patient-prosthesis mismatch compared to the standard Perimount bioprosthesis in patients undergoing aortic valve replacement?
Does the Perimount Magna bioprosthesis improve hemodynamic performance and reduce patient-prosthesis mismatch compared to the standard Perimount bioprosthesis in patients undergoing aortic valve replacement?
The Perimount Magna bioprosthesis provides superior hemodynamics and a lower incidence of patient-prosthesis mismatch compared to the standard Perimount valve, particularly in patients with smaller aortic annuli.
Answers are grounded in this paper and cite their sources.
May favor Magna in small annuli to limit severe PPM; leaves open need for RCTs to confirm benefit.
BACKGROUND: Complete supraannular placement and smaller stent design allow the implantation of a Perimount Magna bioprosthesis with a larger inner diameter than that of a standard Perimount. This study compares the hemodynamic performance and the incidence of patient-prosthesis mismatch (PPM) of both prostheses. METHODS: 128 patients underwent aortic valve replacement, receiving either a Magna (n = 57) or a standard (n = 71) prosthesis. Inner aortic annulus diameter was measured intraoperatively by a hegar dilator to match echocardiographically obtained results to the annulus diameter instead of matching them to labelled valve size. RESULTS: The Magna was significantly superior with respect to mean pressure gradient and effective orifice area in patients with an annulus diameter of 22-23 mm. In patients with an annulus diameter < 22 mm or > 23 mm, there was a non-significant trend towards superior hemodynamics in the Magna group. Severe PPM (effective orifice area index < or = 0.65 cm (2)/m (2)) was present in 11.1% (Magna) vs. 42.1% (Standard) of patients with an annulus diameter < 22 mm; in 0% (Magna) vs. 13.8% (Standard) with an annulus diameter of 22-23 mm; no PPM was seen in patients with annulus diameter > 23 mm in both groups. CONCLUSIONS: The Perimount Magna had a significantly reduced incidence of patient-prosthesis mismatch and superior hemodynamics compared to the standard Perimount.
No takes yet. Share an insight, caveat, or question.
Botzenhardt et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: